This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Okamoto, K.
Right arrow Articles by Taya, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Okamoto, K.
Right arrow Articles by Taya, Y.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, November 2005, p. 9608-9620, Vol. 25, No. 21
0270-7306/05/$08.00+0     doi:10.1128/MCB.25.21.9608-9620.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

DNA Damage-Induced Phosphorylation of MdmX at Serine 367 Activates p53 by Targeting MdmX for Mdm2-Dependent Degradation{dagger}

Koji Okamoto,1* Kenji Kashima,1 Yaron Pereg,2 Michiko Ishida,1 Satomi Yamazaki,1 Ayumi Nota,1 Amina Teunisse,3 Domenico Migliorini,4 Issay Kitabayashi,5 Jean-Christophe Marine,6 Carol Prives,4 Yosef Shiloh,2 Aart G. Jochemsen,3 and Yoichi Taya1

Radiobiology Division, National Cancer Center Research Institute, Tokyo 104-0045, and CREST and SORST, Japan Science and Technology Agency, Tokyo, Japan,1 David and Inez Myers Laboratory for Genetic Research, Department of Human Genetics and Molecular Medicine, Sackler School of Medicine, Tel Aviv University, Tel Aviv 69978, Israel,2 Department of Molecular and Cell Biology, Leiden University Medical Center, 2300 RA Leiden, The Netherlands,3 Department of Biological Sciences, Columbia University, New York, New York 10027,4 Molecular Oncology Division, National Cancer Center Research Institute, Tokyo 104-0045, Japan,5 Laboratory of Molecular Cancer Biology, Flanders Interuniversity Institute for Biotechnology, B-9052 Ghent, Belgium6

Received 17 February 2005/ Returned for modification 15 April 2005/ Accepted 14 August 2005

Understanding how p53 activity is regulated is crucial in elucidating mechanisms of cellular defense against cancer. Genetic data indicate that Mdmx as well as Mdm2 plays a major role in maintaining p53 activity at low levels in nonstressed cells. However, biochemical mechanisms of how Mdmx regulates p53 activity are not well understood. Through identification of Mdmx-binding proteins, we found that 14-3-3 proteins are associated with Mdmx. Mdmx harbors a consensus sequence for binding of 14-3-3. Serine 367 (S367) is located within the putative binding sequence for 14-3-3, and its substitution with alanine (S367A) abolishes binding of Mdmx to 14-3-3. Transfection assays indicated that the S367A mutation, in cooperation with Mdm2, enhances the ability of Mdmx to repress the transcriptional activity of p53. The S367A mutant is more resistant to Mdm2-dependent ubiquitination and degradation than wild-type Mdmx, and Mdmx phosphorylated at S367 is preferentially degraded by Mdm2. Several types of DNA damage markedly enhance S367 phosphorylation, coinciding with increased binding of Mdmx to 14-3-3 and accelerated Mdmx degradation. Furthermore, promotion of growth of normal human fibroblasts after introduction of Mdmx is enhanced by the S367 mutation. We propose that Mdmx phosphorylation at S367 plays an important role in p53 activation after DNA damage by triggering Mdm2-dependent degradation of Mdmx.

* Corresponding author. Mailing address: National Cancer Center Research Institute, Radiobiology Division, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan. Phone: 81 3 3542 2511, ext. 4805. Fax: 81 3 5565 0727. E-mail: kojokamo{at}gan2.res.ncc.go.jp.

{dagger} Supplemental material for this article may be found at http://mcb.asm.org.

Molecular and Cellular Biology, November 2005, p. 9608-9620, Vol. 25, No. 21
0022-538X/05/$08.00+0     doi:10.1128/MCB.25.21.9608-9620.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Zuckerman, V., Lenos, K., Popowicz, G. M., Silberman, I., Grossman, T., Marine, J.-C., Holak, T. A., Jochemsen, A. G., Haupt, Y. (2009). c-Abl Phosphorylates Hdmx and Regulates Its Interaction with p53. J. Biol. Chem. 284: 4031-4039 [Abstract] [Full Text]  
  • Lopez-Pajares, V., Kim, M. M., Yuan, Z.-M. (2008). Phosphorylation of MDMX Mediated by Akt Leads to Stabilization and Induces 14-3-3 Binding. J. Biol. Chem. 283: 13707-13713 [Abstract] [Full Text]  
  • Gilkes, D. M., Pan, Y., Coppola, D., Yeatman, T., Reuther, G. W., Chen, J. (2008). Regulation of MDMX Expression by Mitogenic Signaling. Mol. Cell. Biol. 28: 1999-2010 [Abstract] [Full Text]  
  • Jin, Y., Zeng, S. X., Sun, X.-X., Lee, H., Blattner, C., Xiao, Z., Lu, H. (2008). MDMX Promotes Proteasomal Turnover of p21 at G1 and Early S Phases Independently of, but in Cooperation with, MDM2. Mol. Cell. Biol. 28: 1218-1229 [Abstract] [Full Text]  
  • Hu, B., Gilkes, D. M., Chen, J. (2007). Efficient p53 Activation and Apoptosis by Simultaneous Disruption of Binding to MDM2 and MDMX. Cancer Res. 67: 8810-8817 [Abstract] [Full Text]  
  • Wang, Y. V., Wade, M., Wong, E., Li, Y.-C., Rodewald, L. W., Wahl, G. M. (2007). Quantitative analyses reveal the importance of regulated Hdmx degradation for P53 activation. Proc. Natl. Acad. Sci. USA 104: 12365-12370 [Abstract] [Full Text]  
  • Singh, R. K., Iyappan, S., Scheffner, M. (2007). Hetero-oligomerization with MdmX Rescues the Ubiquitin/Nedd8 Ligase Activity of RING Finger Mutants of Mdm2. J. Biol. Chem. 282: 10901-10907 [Abstract] [Full Text]  
  • Carlessi, L., Buscemi, G., Larson, G., Hong, Z., Wu, J. Z., Delia, D. (2007). Biochemical and cellular characterization of VRX0466617, a novel and selective inhibitor for the checkpoint kinase Chk2. Molecular Cancer Therapeutics 6: 935-944 [Abstract] [Full Text]  
  • Marine, J.-C. W., Dyer, M. A., Jochemsen, A. G. (2007). MDMX: from bench to bedside. J. Cell Sci. 120: 371-378 [Abstract] [Full Text]  
  • Hu, B., Gilkes, D. M., Farooqi, B., Sebti, S. M., Chen, J. (2006). MDMX Overexpression Prevents p53 Activation by the MDM2 Inhibitor Nutlin. J. Biol. Chem. 281: 33030-33035 [Abstract] [Full Text]  
  • Wade, M., Wong, E. T., Tang, M., Stommel, J. M., Wahl, G. M. (2006). Hdmx Modulates the Outcome of P53 Activation in Human Tumor Cells. J. Biol. Chem. 281: 33036-33044 [Abstract] [Full Text]  
  • Buscemi, G., Carlessi, L., Zannini, L., Lisanti, S., Fontanella, E., Canevari, S., Delia, D. (2006). DNA Damage-Induced Cell Cycle Regulation and Function of Novel Chk2 Phosphoresidues. Mol. Cell. Biol. 26: 7832-7845 [Abstract] [Full Text]  
  • Pereg, Y., Lam, S., Teunisse, A., Biton, S., Meulmeester, E., Mittelman, L., Buscemi, G., Okamoto, K., Taya, Y., Shiloh, Y., Jochemsen, A. G. (2006). Differential Roles of ATM- and Chk2-Mediated Phosphorylations of Hdmx in Response to DNA Damage.. Mol. Cell. Biol. 26: 6819-6831 [Abstract] [Full Text]  
  • Tabakin-Fix, Y., Azran, I., Schavinky-Khrapunsky, Y., Levy, O., Aboud, M. (2006). Functional inactivation of p53 by human T-cell leukemia virus type 1 Tax protein: mechanisms and clinical implications. Carcinogenesis 27: 673-681 [Abstract] [Full Text]  
  • Poyurovsky, M. V., Prives, C. (2006). Unleashing the power of p53: lessons from mice and men. Genes Dev. 20: 125-131 [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»